Skip to main content
TipRanks
Go Ultimate75% OFF

Mycenax Biotech Inc. (4726) Balance Sheet

Mycenax Biotech Inc. Balance Sheet

Mycenax Biotech Inc.'s total assets for Q2 2026 were NT$3.28B, a decrease of 1.92% from the previous quarter. TW:4726 total liabilities were NT$1.87B for the fiscal quarter, a 0.78% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 3.26BNT$ 3.37BNT$ 3.77BNT$ 4.45BNT$ 3.14B
NT$ 1.66BNT$ 1.34BNT$ 1.32BNT$ 1.35BNT$ 1.23B
NT$ 1.60BNT$ 2.02BNT$ 2.45BNT$ 3.11BNT$ 1.91B

Currency in TWD

Mycenax Biotech Inc. Liabilities to Assets

02B4B6B24 %36 %48 %60 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets